Skip to main content
Diagnostic Medical Systems logo

Diagnostic Medical Systems — Investor Relations & Filings

Ticker · ALDMS ISIN · FR0012202497 LEI · 969500RKTIGCNNIKIN19 PA Manufacturing
Filings indexed 233 across all filing types
Latest filing 2016-10-05 Regulatory Filings
Country FR France
Listing PA ALDMS

About Diagnostic Medical Systems

https://www.dms.com/en/home/

Diagnostic Medical Systems (DMS) specializes in the development, design, and manufacturing of medical imaging systems. The company's core focus is on digital radiology and bone densitometry. Its product portfolio includes radiography and fluoroscopy systems, mobile x-ray units, surgical C-arms, and bone densitometers. DMS is engaged in developing next-generation imaging solutions aimed at improving patient care and personalized medicine. Key development projects include new mobile and surgical imaging equipment and an advanced range of bone densitometers for diagnosing and monitoring pathologies affecting bone mineral density.

Recent filings

Filing Released Lang Actions
AXS Medical, filiale du groupe DMS, renforce sa force de vente commerciale
Regulatory Filings Classification · 95% confidence The document announces specific business developments for AXS Medical, a subsidiary of DMS Group, including new distribution agreements (Biomod 3D, Capron Podologie) and the hiring of an export manager. This type of announcement details operational changes, partnerships, and strategic movements rather than routine financial reporting (like 10-K, ER, IR) or mandatory regulatory disclosures (like DIRS, DIV). It is a corporate update focused on commercial strategy and expansion. Since it is not a standard financial report, a management discussion (MDA), or a formal regulatory filing (RNS), the closest fit among the provided options for a general business/commercial update that isn't explicitly covered by other codes is often categorized under general corporate news or sometimes related to capital/financing if it involved a major deal, but here it is purely commercial. Given the options, this is a specific corporate announcement about commercial activities and partnerships. It does not fit well into the defined categories like ER, 10-K, or CT. It is not a Director's Dealing (DIRS), Dividend (DIV), or Capital Change (CAP). It is a general business update. In the absence of a specific 'Commercial Update' code, and given that it is not a formal regulatory filing announcement (RPA/RNS) but the content itself, it is best classified as a general corporate announcement. Since 'RNS' is defined as a 'General regulatory announcements and fallback category for miscellaneous filings that do not neatly fit into other specific categories,' and this is a specific, non-financial, non-governance corporate announcement, RNS is the most appropriate fallback.
2016-10-05 French
Mise à disposition du rapport financier semestriel 2016
Report Publication Announcement Classification · 99% confidence The document is titled "MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2016" (Making available of the 2016 Half-Year Financial Report). It explicitly states that the company has made its half-year financial report available to the public and filed it with the AMF (Autorité des marchés financiers). The document itself is very short (2365 characters) and serves only to announce the publication of the full report, rather than containing the comprehensive financial data of the report itself. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating a report has been published points to a Report Publication Announcement (RPA). The period covered is 'semestriel' (half-year), which would typically align with an Interim Report (IR), but since this document is only the announcement of the IR, RPA is the correct classification.
2016-09-30 French
Rapport financier semestriel 2016
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Rapport financier semestriel 2016' (2016 Half-Year Financial Report) for Groupe DMS. It contains comprehensive financial statements, including the statement of financial position, income statement, cash flow statement, and notes to the consolidated financial statements for the period ending June 30, 2016. As it provides substantive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H2 2016
2016-09-30 French
Information relative au nombre total de droits de vote et d'actions composant le capital au 31 août 2016
Share Issue/Capital Change Classification · 95% confidence The document is titled "INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL AU 31 AOUT 2016" (Information relative to the total number of voting rights and shares comprising the capital as of August 31, 2016). It explicitly details the total number of shares and voting rights as of a specific date. This type of periodic disclosure regarding the capital structure and voting rights is most closely aligned with announcements concerning share capital changes or major shareholding notifications, although it is a specific regulatory disclosure often required monthly or quarterly in some jurisdictions. Given the options, it is a specific disclosure about the number of shares and voting rights. This fits best under 'Major Shareholding Notification' (MRQ) as it relates to the composition of the share base, or potentially 'Share Issue/Capital Change' (SHA). However, since it is a periodic statement of the total capital structure rather than a transaction (like a buyback or new issue), and it is a formal disclosure, it is a specific type of capital structure update. In many contexts, disclosures about the total number of shares and voting rights are grouped with major shareholding changes or general capital updates. Given the precise nature of the data (total voting rights and shares), it is a specific regulatory filing. Since there isn't a perfect fit for 'Total Voting Rights Disclosure', I will evaluate the closest options. It is not an ER, IR, or 10-K. It is a direct disclosure of capital structure metrics. 'SHA' (Share Issue/Capital Change) is plausible, but 'MRQ' (Major Shareholding Notification) often covers changes in the total outstanding shares or significant ownership blocks. Since this is a statement of the total, it is a fundamental capital structure disclosure. I will classify this as a specific capital structure update, which aligns best with 'SHA' or 'MRQ'. Given the focus on the total number of shares and voting rights, it is a direct report on the capital base, making SHA a strong candidate, but MRQ is often used for periodic updates on share base composition. Since it is a formal, periodic disclosure of the capital base, and not a transaction announcement, I will lean towards the most specific category related to share base reporting, which is often MRQ in databases that track significant ownership changes, or SHA for general capital structure. Since it is a formal disclosure of the total capital structure, I will select SHA as it directly relates to the 'Capital' component, although it is a very specific type of disclosure. Re-evaluating the definitions: SHA is 'Announcement regarding new share issues, stock splits, or other capital changes.' This document reports the *current state* of the capital, not necessarily a *change*. MRQ is 'Notification of changes in significant share ownership levels (crossing thresholds).' This document reports the total, which underpins MRQ filings. Given the lack of a specific 'Capital Structure Report' code, and that this is a formal, short disclosure, it might fall under RNS if it were purely an announcement, but the content is highly specific. In many European contexts, this is a mandatory periodic disclosure related to the total share capital. I will classify it as SHA as it is the most relevant category concerning the total share count, even if no *change* is explicitly announced in this snapshot. However, if this is a mandatory disclosure of the total capital base, it is often categorized under general regulatory filings if a specific code isn't available. Given the high specificity of the data (total voting rights and shares), it is a fundamental capital structure report. I will select SHA (Share Issue/Capital Change) as the closest fit for reporting on the total number of shares comprising the capital. Confidence is high due to the explicit nature of the content matching capital structure reporting.
2016-09-02 French
Forum Boursorama : DMS poursuivra les auteurs des messages diffamatoires ou dénigrants
Legal Proceedings Report Classification · 99% confidence The document is a short press release dated 31/08/2016 concerning legal actions taken by Diagnostic Medical Systems (DMS) against former executives and individuals posting defamatory messages on the Boursorama forum. It details ongoing legal proceedings (injunctions, defamation suits) and the impact on the company's stock price. This type of announcement, detailing significant legal matters or regulatory actions against the company, fits best under the 'Legal Proceedings Report' category. It is not a comprehensive financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). Given its nature as a specific update on litigation, LTR is the most appropriate classification.
2016-08-31 French
Chiffre d'affaires du 1er semestre 2016 : 17,0 MEUR - Progression soutenue du périmètre historique : +14%
Earnings Release Classification · 100% confidence The document is a press release announcing the consolidated revenue for the first half of 2016. It provides key financial highlights (revenue figures, growth percentages) but explicitly states that the full 'semestriels' (interim) results will be published at a later date (September 30, 2016). Since this is an initial announcement of financial highlights rather than the full interim report, it is classified as an Earnings Release. H1 2016
2016-08-25 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.